NITI Aayog (health) member VK Paul said that not only Bharat Biotech's Covaxin, but Zydus Cadila's vaccine is already being tested on children.
Ahmedabad-based Zydus Cadila is trying its Covid-19 immunization competitor on offspring of in the age gathering of 12-18 years, aside from grown-ups, and the Ahmedabad-based organization is probably going to apply for licensure of the antibody in next about fourteen days, a senior government official has said.
“Not only Covaxin is conducting child trials—and they will not take long because they are all immunogenic trials—but also Zydus vaccine is already being tested on children. So when Zydus comes for licensure, hopefully in the next two weeks, maybe we will also have enough data on the view whether that vaccine can be given to children,” NITI Aayog (health) member VK Paul said during the briefing of the health ministry on Friday.
"We have to understand that the child cohort is not a small cohort. My rough guess is that if it is between 12 and 18 years, this itself is about 13 to 14 crore population and for which we will need about 25-26 crore doses,” "We cannot have some people getting and others not getting. So we will have to take this into account when we strategise and make a decision based on how many doses of which vaccines are available," he said.
Source : Hindustan Times
The National Commission for Protection of Child Rights (NCPCR|) has pulled up the Delhi authorities over a promotional video. A criticism on this rega...
The frame of an unidentified guy with one in every of his wrists chopped off turned into discovered close to the farmers’ protest web website on...